Technology-enabled Type 1 Diabetes Education and Support (T1DES)System

DESCRIPTION (provided by applicant): Management of Type 1 diabetes requires vigilant monitoring by patients who often encounter numerous barriers that can impede proper management. Barriers can include educational, psychosocial, and support issues. PolarisHealth Directions, a small business, and University of Pennsylvania School of Nursing have partnered to develop the Technology-enabled Type 1 Diabetes Education and Support (T1DES) system that will assist and support diabetes management by providing: (1)an automated, web-based management assessment (skills, knowledge, barriers, routine screenings for complications) that can be completed on any internet-connected personal or tablet computer; (2) real time patient report with tailored educational materialsand support; (3) real time 1-page clinician report that highlights psychosocial issues, barriers to management, and need for routine screening; (4) e-learning tools (web-based learning modules and webinars); (5) enhanced messaging systems (EMS; i.e., automated text messaging and emails) to send patient reminders and to support diabetes management between office visits, and (6) the capability to be integrated into electronic health records (EHR) via HL7 interface and automate referrals to mental health providers, social workers, and diabetes specialists. In Phase I, a pilot study will be conducted to demonstrate the feasibility and potential of T1DES to support diabetes management through e-assessment, e-learning and e-messaging. Specific Aim 1: Develop theT1DES prototype based on end-user interviews (patient, family members, diabetes providers); finalize educational modules and e-messaging content; design assessment and reports; write and test T1DES software; train clinicians to use the system, and conducta Field Test at the Diabetes Center for Children at Children's Hospital of Philadelphia (Months 1-6). Specific Aim 2: Conduct a Pilot Study and evaluate the acceptance of the system by end-users (Months 6-12).The Pilot Study will enroll 40 patients (13-18years old) and 40 family members involved in the patient's diabetes management. Patients will complete the assessment, set goals to achieve before their next appointment, and receive a tailored, educational feedback report that will be reviewed with a diabetes provider. The patient will then receive e-messages daily for 3-months based on the diabetes management goals they have selected. Additionally, family members and patients will receive appointment reminders and have access to online e-learning tools (educational modules and webinars).Three months after enrolling in the study, participants will be asked to complete a satisfaction survey regarding the educational and supportive benefits of the T1DES system, readability, and ease of use that will help inform further product development. In Phase II, a multi-site randomized controlled trial will be conducted to examine T1DES impact on HbA1C, management skills, knowledge, and barriers, medical outcomes, and healthcare utilization over a one year period. OtherPhase II goals will include: integration with EHR; development of a web-based multimedia training for clinicians; and interactive provider-patient text and voice messaging. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: T1DES will make substantial contributions to public health and to diabetes research. It will improve management for Type 1 diabetes, reducing both the costs and suffering associated with poor diabetes control. It can be readily adapted for use with Type 2 diabetes. It will contribute to knowledge regarding the feasibility of using electronic messaging systems (EMS) and e-learning tools to improve diabetes self-management across a diverse sample of youths, and identify race/ethnicity and gender preferences and satisfaction with EMS and e-learning tools.